Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844090 · ClinicalTrials.gov registry record · NA
The Role of Apathy in Glycemic Control
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT00844090 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 106 participants.
The verdict
NCT00844090, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
In spite of several new medications and insulins for the control of blood sugars in patients with diabetes, a large number of patients do not have good control. This likely due to inability to carry out regular activities and self-care behaviors such as taking meds regularly, keeping a good diet, exercise etc. This inability to carry out self care lifestyle changes may be due to a condition called apathy. Apathy is a lack of motivation and persistence. In this study we will attempt to treat apathy with a medication called methylphenidate for 6 months and see if blood sugar/diabetes control improves.
Interventions
- DRUG methylphenidate or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00844090
The ClinicalTrials.gov registry entry for NCT00844090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methylphenidate or placebo is the first listed.
NCT00844090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00844090 about?
NCT00844090 is a clinical study titled "The Role of Apathy in Glycemic Control". In spite of several new medications and insulins for the control of blood sugars in patients with diabetes, a large number of patients do not have good control. This likely due to inability to carry out regular activities and self-care behaviors such as taking meds regularly, keeping a good diet, ex...
What is the current status of trial NCT00844090?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2009-07. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00844090?
The interventions under investigation include: methylphenidate or placebo (DRUG).
Who is sponsoring clinical trial NCT00844090?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.